During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers , Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow -1.08% to 11826. S&P -1.12% to 1212. Nasdaq -1.56% to 2233.
Treasurys: 30-year +1.06%. 10-yr +0.28%. 5-yr -0.426%.
Commodities: Crude -5.18% to $94.95. Gold -5.22% to $1576.25.
Currencies: Euro -0.43% vs. dollar. Yen +0.06%. Pound +0.07%
After Hours Earning News:
Lam Research (LRCX) agrees to acquire Novellus Systems (NVLS) in an all-stock transaction valued at $3.3B. NVLS shareholders will receive 1.125 shares of LRCX for each of their shares, valuing NVLS at $44.42/share, or ~12.5% above its closing price today. Lam also announces a $1.6M common stock repurchase program. NVLS +10.2% before trading halted, LRCX -3% AH
VeriFone (PAY): FQ4 EPS of $0.53 beats by $0.02. Revenue of $410M (+51% Y/Y) in-line
DFC Global (DLLR) announces its Board of Directors has approved a 5M share stock buyback. Shares +0.6% AH.
Aetna (AET) gains 1% AH after using an 8-K to lift its 2011 EPS guidance to $5.15 from $5, and its 2012 EPS guidance to $5 from $4.80. The company also says it will have 18.4M members enrolled in medical plans at year's end, but that this figure will decline to 17.9M by the end of Q1 2012. Aetna is hosting its annual investor conference tomorrow.
BioSante (BPAX -15.5%) plunged in late trading, and a PR issued after the bell provides the likely reason. The company says its LibiGel drug failed to achieve its primary endpoints during Phase III trials. The company says it will continue to analyze trial data, so as to determine its next step
Nordson (NDSN) drops 5.7% AH after posting FQ4 results. Revenue of $331M (+14% Y/Y) beat by $10.5M, and EPS of $0.81 was in-line. However, the company is guiding for FQ1 revenue of $270M-$281M and EPS of $0.54-$0.61, below a consensus of $288.9M and $0.68. Nordson and other industrial equipment makers are often seen as bellwethers for broader manufacturing-related activity.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
